Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $99.88M.
ENTERPRISE VALUE (EV)
$99.88M
Cumberland Pharmaceuticals Inc.
Market Cap
$106.08M
Enterprise Value (EV)
$99.88M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cumberland Pharmaceuticals Inc. (CPIX) | $106.08M | $99.88M |
| Definitive Healthcare Corp. (DH)vs › | $105.38M | $101.57M |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | $93.13M |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.30M | $106.08M |
| Anixa Biosciences, Inc. (ANIX)vs › | $103.77M | $102.55M |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.57M | $89.47M |
| OnKure Therapeutics, Inc. (OKUR)vs › | $103.06M | N/A |
| The Joint Corp. (JYNT)vs › | $103.00M | $82.88M |
| Apyx Medical Corporation (APYX)vs › | $109.49M | $121.50M |
| Outlook Therapeutics, Inc. (OTLK)vs › | $109.54M | $116.73M |
Market Cap
$106.08M
Total Debt
$5.24M
Cash
$11.44M
Enterprise Value
$99.88M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
